Business Wire - September 18, 2009
- MEDIA ADVISORY:
WHAT: International Symposium "Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV." More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an AIDS vaccine.
Media Briefing by two experts from the IAVI/Scripps Research team that recently discovered two new broadly neutralizing antibodies to HIV that reveal a previously unknown site on the virus that could prove a good target for vaccine design. They will discuss the implications of their work, which was published in the September 3 online edition of the journal Science, and the research road ahead.
One-on-one interviews with Wayne Koff, senior vice president of research and development at IAVI, and Dennis R. Burton, scientific director of the IAVI Neutralizing Antibody Consortium and Scripps Research professor in the Department of Immunology.
Laboratory tour for B-roll
Interview opportunities with presenting and attending scientists during symposium breaks
WHERE:
Beckman Center for Chemical Sciences at The Scripps Research Institute | 10550 North Torrey Pines Road, La Jolla, California 92037
Symposium: Lower Level, Beckman Center
Media briefing: 4th Floor Atrium Meeting Room, Beckman Center
WHEN: Thursday, September 24
Symposium: 8:30 AM to 5:00 PM PDT
Media Briefing: 10:15 to 10:45 AM PDT
Briefing Call-in: Dial toll-free 1-866-618-6746; when prompted, enter access code 3579711 followed by #.
RSVP TO ATTEND
Please contact Keith McKeown kmckeown@scripps.edu; 858-784-8134 or Rachel Steinhardt rsteinhardt@iavi.org; 212-847-1045
YOU MUST CALL AHEAD FOR PARKING
Daphne Lovelette at Scripps Research, daphnel@scripps.edu; 858-784-9127
Contacts
The Scripps Research Institute
Keith McKeown, 858-784-8134
kmckeown@scripps.edu
or
IAVI
Rachel Steinhardt, 212-847-1045
rsteinhardt@iavi.org
090918
BW090926
Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .